Feed Preview

Going Viral

Huntington’s Disease - HTT Structure & Function (MDS)

Huntington’s Disease - HTT Structure & Function (MDS) diagram by Swaminathan et al, Wikimedia
Swaminathan et al, Wikimedia

Huntington’s disease (HD) is a hereditary neurodegenerative disease caused by mutations in the HTT gene which encodes the huntingtin protein. HD is characterized by poor coordination and involuntary body movements. Here is the latest research on the structure and function of huntingtin.

Top 20 most recent papers
Proceedings of the National Academy of Sciences of the United States of America

Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23

Proceedings of the National Academy of Sciences of the United States of AmericaJuly 28, 2019
Svitlana YablonskaRobert M Friedlander
7
1
15
Human Molecular Genetics

Nemo-like Kinase Reduces Mutant Huntingtin Levels and Mitigates Huntington's Disease

Human Molecular GeneticsApril 4, 2020
Mali JiangWenzhen Duan
100
4
4
51
ACS Applied Materials & Interfaces

Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington's Disease

ACS Applied Materials & InterfacesSeptember 4, 2019
Wenshu CongChunying Chen
8
1
14
Science Translational Medicine

Astrocyte molecular signatures in Huntington's disease

Science Translational MedicineOctober 18, 2019
Blanca Diaz-CastroBaljit S Khakh
70
7
2
42
1
Movement Disorders Clinical Practice

Characterizing White Matter in Huntington's Disease

Movement Disorders Clinical PracticeJanuary 24, 2020
Sarah GregoryEdward J Wild
26
1
1
Frontiers in Immunology

Expression of Human Mutant Huntingtin Protein in Drosophila Hemocytes Impairs Immune Responses

Frontiers in ImmunologyNovember 5, 2019
Yu-Hsien LinMichal Zurovec
5
1
9
5
1
1
16
Frontiers in Molecular Biosciences

The Role of Post-translational Modifications on the Energy Landscape of Huntingtin N-Terminus

Frontiers in Molecular BiosciencesOctober 22, 2019
Havva YalincaAnnalisa Pastore
5
1
7
Journal of Korean Neurosurgical Society

An Optimization of AAV-82Q-Delivered Rat Model of Huntington's Disease

Journal of Korean Neurosurgical SocietyMarch 6, 2020
Kyoung-Ha SoYoung Seok Park
2
1
Brain Sciences

Therapeutic Advances for Huntington's Disease

Brain SciencesJanuary 17, 2020
Ashok KumarJong-Joo Kim
3
1

See more papers from this feed

Related Feeds

Allen Institute for Brain Science Network (MDS)

The Allen Institute for Brain Science Network is a not-for-profit biomedical research organization that provides open access to multiple neuroscience tools and resources. Find the latest research from tjr Allen Institute for Brain Science Network here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Antibody Therapeutics (MDS)

Alpha-synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. They have also been detected in several other neurodegenerative diseases, known as synucleopathies. Here is the latest research on alpha-synuclein antibody therapeutics.

Astrocytes & Huntington’s Disease (MDS)

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Autophagy: Cancer & Parkinson (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

BRAIN Initiative Cell Census Network (MDS)

The BRAIN Initiative Cell Census Network aims to identify and provide experimental access to the different brain cell types to determine their roles in health and disease. Discover the latest research from researchers in the BRAIN Initiative Cell Census Network here.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/huntingtons-disease---htt-structure-function/a70d8eb2-2cd6-4fb8-895d-e532c0ba091e